Articles Mentioning Healthcare Equipment and Supplies Stocks

Results 1 - 10 of 323 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare Equipment and Supplies

Investing | April 28, 2016

3 Scorching Hot Med-Tech Stocks In 2016

Edwards Lifesciences, Abiomed, and Boston Scientific are producing eye-popping returns lately.

Investing | June 17, 2014

Why the Medtronic-Covidien Merger Is a Perfect Match

Medtronic rocked the health care world with the largest medical device acquisition in history, but this big buy is a huge step in the right direction for the world's largest pure device maker and its investors.

Investing | April 02, 2014

Has This Once-Hot Med Tech Innovation Flatlined?

Renal denervation, the once-promising treatment for high blood pressure, has fizzled out after a failed trial from Medtronic.

Investing | February 26, 2014

Does This Johnson & Johnson Product Have Blockbuster Potential?

JNJ's European approval for a renal denervation device was unexpected, but more work needs to be done.

Investing | February 14, 2014

High Expectations for Growth: Is CR Bard Overvalued?

Bard has significantly improved its growth outlook, but Wall Street seems a step or two ahead.

Investing | January 26, 2014

1 Innovative Growth Market on the Verge of Collapse

Hypertension treatment renal denervation has been a hot topic in the medical device industry, but a recent trial disappointment from Medtronic has companies like Covidien and Boston Scientific backpedaling.

Investing | January 17, 2014

Has This Hot Med Tech Market Frozen Over?

Renal denervation's a huge opportunity for Medtronic, St. Jude Medical, and other leading device companies, but recent setbacks have investors wondering how long it will be before potential translates into results

Investing | January 09, 2014

Medtronic's Surprising Update Spikes Blood Pressures Across Med-Tech

A potential $3 billion/year therapy may not work nearly as well as hoped.

Investing | November 22, 2013

A Trio of Stock Prospects in Medical Devices

What is the outlook for AngioDynamics, DexCom, and Abiomed?

Investing | November 16, 2013

Here's Why Boston Scientific Bought C.R. Bard's Electrophysiology Business

Boston Scientific is cutting costs in a bid to return to profitability. So, why did the company spend $275 million to acquire the electrophysiology business from competitor C.R. Bard?

Results 1 - 10 of 323 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Healthcare Equipment and Supplies